Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,150 public trials 2,021 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

ColoSeal™ ICD System Safety and Feasibility Study

NCT06402188

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • National Center of Oncology after V.A. Fanarjian Yerevan, Armenia
  • Israeli-Georgian Medical Research Clinic Healthycore Tbilisi, Georgia
  • National Cancer Institute Tashkent, Uzbekistan
View Trial Details
Recruiting

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT04678648

Conditions
Advanced Malignant Solid Neoplasm, Astrocytoma, Colon Cancer, +35 more
Locations
  • University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon, SCRI Oncology Partners - Health One Denver, Colorado, United States
  • Sarah Cannon, SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

NCT06038578

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope at Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California, Los Angeles Santa Monica, California, United States
  • Texas Oncology Arlington North Arlington, Texas, United States
View all 27 locations
View Trial Details

Related conditions